Cover Image
Market Research Report

Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2019 - 2024)

Published by Mordor Intelligence LLP Product code 649746
Published Content info 115 Pages
Delivery time: 2-3 business days
Back to Top
Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2019 - 2024)
Published: March 1, 2019 Content info: 115 Pages

Market Overview

The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.

The usage of synthetic oligonucleotides has been increasing rapidly over the past decade, owing to several benefits offered by molecular diagnostics and growing clinical applications. The nucleic acid application techniques are the reference methods and are very useful for carrying out the molecular diagnosis in several diseases, like for the detection of infectious diseases, such as hepatitis.

Synthetic oligonucleotides also have significant clinical applications, primarily for the detection of autoimmune antibodies. There have been consistent developments in synthetic biology over the past few years, where synthetic oligonucleotides were used to develop assays for the detection of anti-double-stranded DNAs. Thus, all these factors are responsible for the growth of the oligonucleotide synthesis market.

In addition, there are also other major factors influencing the market for oligonucleotide synthesis. This includes the increasing advancement in the field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investment by the government for the development of genomic technologies, and the increasing demand for oligonucleotide synthesis technologies by the public and private research firms.

Scope of the Report

As per the scope of the report, oligonucleotides are short fragments of nucleic acids that are synthesized using genetic engineering and enzyme chemistry. These are mostly used in laboratories in applications, such as therapeutic, diagnostics, as well as academic and industrial. These are used from initial research and screening through to target validation and drug production. Nowadays, subsequent improvements in oligonucleotide synthesis, amplification, and automation have completely revolutionized biological research. It is also possible to do the customizations and get the required sequence online easily and at the required time. These services vary greatly by the cost of per base pair, error rates, lengths, throughput, etc.

Key Market Trends

Academic Research Institutes are the Largest Segment Under End User that is Expected to Grow in the Forecast Period

The government and private entities are found investing in the development of academic and research infrastructure in the emerging economies. This factor is positively boosting the oligonucleotide adoption in academic research institutes. There is an increase in the genomic research projects conducted by academic research institutes that have enabled the segment to account for the dominant share in the market.

North America is the Largest Growing Segment and is Expected to Follow the Same Trend Over the Forecast Period

North America dominates the market due to the presence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region. Furthermore, the strong foothold of North America in genomics, proteomics, oncology, diagnostic screening, and drug discovery has significantly contributed to maintaining its large share.

Competitive Landscape

The companies are seen adopting various strategies adopted by the competitors that include the acquisition of players in emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolio that helps to drive the overall market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 60475

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
    • 4.2.2 The Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
  • 4.3 Market Restraints
    • 4.3.1 Price Erosion of Synthesized Oligonucleotides
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product Type
    • 5.1.1 By Synthesized Oligonucleotide Product
      • Primers
      • Probes
      • Large-scale Synthesis Oligonucleotides
      • Intermediate-scale Synthesis Oligonucleotides
      • Other Synthesized Oligonucleotide Product Types
    • 5.1.2 By Reagents
    • 5.1.3 By Equipment
  • 5.2 By Application
    • 5.2.1 By Research
      • PCR
      • QPCR
      • Sequencing
      • Gene Synthesis
      • Other Research Application
    • 5.2.2 By Diagnostics
    • 5.2.3 By Therapeutics
      • RNAi
      • Nucleic Acid Aptamers
      • DNA/Antisense Oligonucleotides
      • Other Therapeutics
  • 5.3 By End User
    • 5.3.1 Academic Research Institutes
    • 5.3.2 Pharmaceutical and Biotechnology Companies
    • 5.3.3 Diagnostic Laboratories
  • 5.4 Geography
    • 5.4.1 North America
      • US
      • Canada
      • Mexico
    • 5.4.2 Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.4.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 5.4.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 Bio-Synthesis Inc.
    • 6.1.5 Eurofins Genomics
    • 6.1.6 Eurogentec
    • 6.1.7 GE Healthcare
    • 6.1.8 GenScript
    • 6.1.9 Integrated DNA Technologies Inc.
    • 6.1.10 LGC Biosearch Technologies


Back to Top